Drug Profile
Birch pollen allergy vaccine - HAL Allergy
Alternative Names: SUBLIVAC FIX Birch; Sublivac Fix BirchLatest Information Update: 22 Aug 2019
Price :
$50
*
At a glance
- Originator HAL Allergy
- Class Allergens; Peptide vaccines; Peptides; Skin disorder therapies; Tree pollen allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Allergic rhinitis; Allergic rhinoconjunctivitis
Most Recent Events
- 22 Aug 2019 Discontinued - Phase-III for Allergic rhinitis in Belgium, Slovakia, Slovakia, Czech Republic, Poland, Poland (Sublingual)
- 22 Aug 2019 Discontinued - Phase-III for Allergic rhinoconjunctivitis in Belgium, Slovakia, Czech Republic, Czech Republic, Poland, Poland (Sublingual)
- 30 Apr 2013 HAL Allergy completes a phase II trial in Allergic rhinitis and Allergic rhinoconjunctivitis in Czech Republic, Germany and Poland (NCT01639768)